The global digital therapeutics market is projected to reach USD 6.9 billion by 2025 from USD 2.1 billion in 2020, at a CAGR of 26.7% during the forecast period (2020–2025). The growth of the digital therapeutics market is primarily driven by factors such as government initiatives for preventive healthcare , technological advancements in mobile healthcare, a significant increase in venture capital investments, and the benefits of digital therapeutics, such as the ability to induce behavioral change ( an important challenge in healthcare), user-friendliness, patient convenience, and improved drug compliance.
Digital Therapeutic (DTx) Market by Application (Prediabetes, Nutrition, Care, Diabetes, CVD, CNS, CRD, MSD, GI, Substance Abuse, Rehabilitation), Sales Channel (B2C, Patient, Caregiver, B2B, Providers, Payer, Employer, Pharma)-Global forecasts to 2025
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724
Rising healthcare costs, the growing prevalence of chronic diseases, and the ability of digital therapeutics to provide cost-effective solutions are some factors responsible for driving the market for treatment / care-related digital therapeutics applications.
Key Questions Addressed by the Report
- Where will these developments take the industry in the mid to long-term?
- What types of annual and multi-year partnerships are companies in the digital therapeutics market exploring?
- Who are the key players in the market, and how intense is the competition?
- What are the recent contracts and agreements that key players have signed?
- What are the recent trends affecting digital therapeutics market players
Get More Information @https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=51646724
Rising healthcare costs, the growing prevalence of chronic diseases, and the ability of digital therapeutics to provide cost-effective solutions are some factors responsible for driving the market for treatment/care-related digital therapeutics applications.The global digital therapeutics market is projected to reach USD 6.9 billion by 2025 from USD 2.1 billion in 2020, at a CAGR of 26.7% during the forecast period (2020–2025).The growth of the digital therapeutics market is primarily driven by factors such as government initiatives for preventive healthcare, technological advancements in mobile healthcare, a significant increase in venture capital investments, and the benefits of digital therapeutics, such as the ability to induce behavioral change (an important challenge in healthcare), user-friendliness, patient convenience, and improved drug compliance.The Digital Therapeutic (DTx) Market is Segmented on:1.
Sales ChannelBrowse 134 market data Tables and 27 Figures spread through 166 Pages.Download PDF Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=516467241B2B segment is expected to grow at the highest CAGR during the forecast periodBased on the sales channel, the digital therapeutics market is segmented into business-to-customer (B2C) and business-to-business (B2B).
In 2019, the B2B segment accounted for the largest market share; it is also expected to grow at the highest CAGR of the digital therapeutics market.Caregivers segment is expected to dominate the marketBased on the type of buyer, the B2C sales channel market is further segmented into patients and caregivers.
The caregivers segment is expected to dominate the market and register the highest CAGR during the forecast period.
The high growth of this segment is attributed to company initiatives for the development of products specifically for caregivers and the fact that digital therapeutics help caregivers in better managing their patients.Regional Growth, Development and Demand Analysis:The global digital therapeutics market is segmented into North America, Europe, the Asia Pacific, and the RoW.
In 2019, North America (US and Canada) held the largest share of the market, followed by Europe.
The study involved four major activities in estimating the current size of the global digital therapeutics market.
The next step was to validate these findings, assumptions, and sizing values with industry experts across the value chain through primary research.
Both top-down and bottom-up approaches were employed to estimate the total market size.Major Growth Drivers:The growth of the digital therapeutics market is primarily driven by factors such as government initiatives for preventive healthcare, technological advancements in mobile healthcare, a significant increase in venture capital investments, and the benefits of digital therapeutics, such as the ability to induce behavioral change (an important challenge in healthcare), user-friendliness, patient convenience, and improved drug compliance.Expected Revenue Growth:The global digital therapeutics market is projected to reach USD 6.9 billion by 2025 from USD 2.1 billion in 2020, at a CAGR of 26.7% during the forecast period (2020–2025).Accessories to Fuel the Growth of Digital Therapeutic (DTx) Market :DTx solutions can be bought or sold in two ways i.e.
The B2B channel accounted for the largest share of the market in 2019.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724Caregivers segment is expected to dominate the marketBased on the type of buyer, the B2C sales channel market is further segmented into patients and caregivers.
The caregivers segment is expected to dominate the market and register the highest CAGR during the forecast period.
The high growth of this segment is attributed to company initiatives for the development of products specifically for caregivers and the fact that digital therapeutics help caregivers in better managing their patients.The treatment/care-related applications segment accounted for the largest share of the digital therapeutics market in 2019.Based on the application, the digital therapeutics market is segmented into preventive and treatment/care-related applications.
Digital therapeutics (DTx) deliver therapeutic interventions directly to patients using employing evidence-based, remote assessed software to serve, manage and avert a broad spectrum of behavioural, mental and physical disorders.
Get More Insight About the Europe Digital Therapeutic (DTx) Market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=europe-digital-therapeutics-market The digital therapeutic (DTx) market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market.
To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.Digital therapeutic (DTx) Market Scope and Market SizeThe digital therapeutic (DTx) market is categorized into four segments which are based on product and service type, application, purchase mode and sales channel.
The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.On the basis of product and service type, the digital therapeutic (DTx) market is segmented into hardware products, solutions/software and service.
Strategic Initiatives by Manufacturers is Creating New Opportunities for Players in the Digital Therapeutic (DTx) MarketThe digital therapeutic (DTx) market also provides you with detailed market analysis for every country growth in digital therapeutic (DTx) product sales, impact of advancement in the digital therapeutic (DTx) and changes in regulatory scenarios with their support for the digital therapeutic (DTx) market.
Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve.
Increasing prevalence of chronic diseases such as diabetes, hypertension among others as well as the rising awareness by government agencies will increase the growth of the digital therapeutic (DTx) market.Digital therapeutics (DTx) deliver therapeutic interventions directly to patients using employing evidence-based, remote assessed software to serve, manage and avert a broad spectrum of behavioural, mental and physical disorders.
Get More Insight About the North America Digital Therapeutic (DTx) Market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=north-america-digital-therapeutics-market The digital therapeutic (DTx) market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market.
To understand the analysis and the digital therapeutic (DTx) market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.Digital Therapeutic (DTx) Market Scope and Market SizeThe digital therapeutic (DTx) market is categorized into four segments which are based on product and service type, application, purchase mode and sales channel.
The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.On the basis of product and service type, the digital therapeutic (DTx) market is segmented into hardware products, solutions/software and service.
The U.S. has the highest household spending in the world and offers trade agreements with several countries making it the largest market for consumer products including digital therapeutic (DTx) productsStrategic Initiatives by Manufacturers is creating new opportunities for Players in the Digital Therapeutic (DTx) MarketThe digital therapeutic (DTx) market also provides you with detailed market analysis for every country growth in digital therapeutic (DTx) product sales, impact of advancement in the digital therapeutic (DTx) and changes in regulatory scenarios with their support for the digital therapeutic (DTx) market.
Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve.
